Becton Dickinson Shares Outstanding 2010-2024 | BDX

Becton Dickinson shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Becton Dickinson shares outstanding for the quarter ending September 30, 2024 were 0.291B, a 0.77% increase year-over-year.
  • Becton Dickinson 2024 shares outstanding were 0.291B, a 0.91% increase from 2023.
  • Becton Dickinson 2023 shares outstanding were 0.288B, a 0.36% increase from 2022.
  • Becton Dickinson 2022 shares outstanding were 0.287B, a 1.62% decline from 2021.
Becton Dickinson Annual Shares Outstanding
(Millions of Shares)
2024 291
2023 288
2022 287
2021 292
2020 282
2019 275
2018 265
2017 224
2016 218
2015 208
2014 198
2013 199
2012 209
2011 226
2010 240
2009 247
Becton Dickinson Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 291
2024-06-30 290
2024-03-31 290
2023-12-31 291
2023-09-30 288
2023-06-30 288
2023-03-31 286
2022-12-31 285
2022-09-30 287
2022-06-30 287
2022-03-31 287
2021-12-31 287
2021-09-30 292
2021-06-30 292
2021-03-31 294
2020-12-31 293
2020-09-30 282
2020-06-30 285
2020-03-31 275
2019-12-31 275
2019-09-30 275
2019-06-30 274
2019-03-31 270
2018-12-31 274
2018-09-30 265
2018-06-30 274
2018-03-31 267
2017-12-31 230
2017-09-30 224
2017-06-30 221
2017-03-31 218
2016-12-31 218
2016-09-30 218
2016-06-30 217
2016-03-31 217
2015-12-31 216
2015-09-30 208
2015-06-30 215
2015-03-31 200
2014-12-31 197
2014-09-30 198
2014-06-30 197
2014-03-31 197
2013-12-31 198
2013-09-30 199
2013-06-30 199
2013-03-31 198
2012-12-31 200
2012-09-30 209
2012-06-30 205
2012-03-31 210
2011-12-31 218
2011-09-30 226
2011-06-30 224
2011-03-31 225
2010-12-31 233
2010-09-30 240
2010-06-30 238
2010-03-31 241
2009-12-31 243
2009-09-30 247
2009-06-30 246
2009-03-31 246
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36